drugset / Trial / NCT06164392
Evaluation of Neuroma Perfusion with Indocyanine Green Fluorescence Angiography
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to characterize the perfusion of neuromas using indocyanine green fluorescence angiography
Timeline
- Start
- 2024-12-28
- Primary completion
- 2024-12-28
- Completion
- 2024-12-28
Outcome
Outcome not reported
Stopped (Enrollment): “The attendings who were to participate did not want to alter their standard neuroma treatment of neurotomy and TMR, as opposed to dissecting the end of all neuromas before neurotomy. No patients were enrolled in the study.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Indocyanine Green | Diagnostic / imaging agent | — | Intravenous |